AU3025695A - Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants, and its use - Google Patents

Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants, and its use

Info

Publication number
AU3025695A
AU3025695A AU30256/95A AU3025695A AU3025695A AU 3025695 A AU3025695 A AU 3025695A AU 30256/95 A AU30256/95 A AU 30256/95A AU 3025695 A AU3025695 A AU 3025695A AU 3025695 A AU3025695 A AU 3025695A
Authority
AU
Australia
Prior art keywords
antidote
employment
pharmaceutical
blood anticoagulants
anticoagulants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU30256/95A
Other versions
AU708409B2 (en
Inventor
Karl-Heinz Diehl
Jurgen Romisch
Hans-Arnold Stohr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU3025695A publication Critical patent/AU3025695A/en
Application granted granted Critical
Publication of AU708409B2 publication Critical patent/AU708409B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU30256/95A 1994-08-26 1995-08-24 Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants, and its use Ceased AU708409B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4430204 1994-08-26
DE4430204A DE4430204A1 (en) 1994-08-26 1994-08-26 Medicament, which is suitable as an antidote for blood anticoagulants and its use

Publications (2)

Publication Number Publication Date
AU3025695A true AU3025695A (en) 1996-03-07
AU708409B2 AU708409B2 (en) 1999-08-05

Family

ID=6526563

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30256/95A Ceased AU708409B2 (en) 1994-08-26 1995-08-24 Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants, and its use

Country Status (8)

Country Link
EP (1) EP0700682A3 (en)
JP (1) JP3838680B2 (en)
KR (1) KR960006920A (en)
AU (1) AU708409B2 (en)
CA (1) CA2156990A1 (en)
DE (1) DE4430204A1 (en)
IL (1) IL115057A0 (en)
ZA (1) ZA957140B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625642A1 (en) * 1996-06-26 1998-01-08 Max Planck Gesellschaft A process for preparing an antidote precursor for natural and synthetic thrombin inhibitors
KR20030031380A (en) * 2001-10-13 2003-04-21 이우진 Skateboard
WO2003099324A1 (en) * 2002-05-23 2003-12-04 Chugai Seiyaku Kabushiki Kaisha Agent neutralizint tissue factor inhibitor and agent neutralizing activated blood coagulation factor viii preparation
KR20040046045A (en) * 2002-11-26 2004-06-05 김재영 Paduk board and chess board that use copper material and maunfacturing method thereof
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
MX2007012704A (en) 2005-04-13 2008-01-14 Astrazeneca Ab A host cell comprising a vector for production of proteins requiring gamma-carboxylation.
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
AU2011313505B2 (en) * 2010-10-06 2015-09-17 Medimmune Limited Factor II and fibrinogen for treatment of haemostatic disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5850202B2 (en) * 1977-11-10 1983-11-09 第一製薬株式会社 Production method of prothrompin
DE3043857A1 (en) * 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg METHOD FOR THE PRODUCTION OF BLOOD coagulation FACTORS AND THE PREPARATION OF FACTORS II AND VII THEREFORE PRODUCED
DD251078A1 (en) * 1986-07-17 1987-11-04 Bezirksinstitut Fuer Blutspend PROCESS FOR THE PREPARATION OF PROTHROMBIN CONCENTRATES
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
AU3098289A (en) 1988-03-04 1989-09-07 Biogen, Inc. Hirudin peptides
JPH0219400A (en) * 1988-07-07 1990-01-23 Green Cross Corp:The Production of thrombin or prothronbin
US5240913A (en) 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
EP0512011B1 (en) * 1990-01-26 1994-04-06 IMMUNO Aktiengesellschaft Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process
DE4203965A1 (en) * 1992-02-11 1993-08-12 Max Planck Gesellschaft ANTIDOT FOR HIRUDIN AND SYNTHETIC THROMBIN INHIBITORS
AT397391B (en) * 1992-05-15 1994-03-25 Immuno Ag USE OF PROTHROMIN FRAGMENTS

Also Published As

Publication number Publication date
ZA957140B (en) 1996-03-26
AU708409B2 (en) 1999-08-05
EP0700682A2 (en) 1996-03-13
IL115057A0 (en) 1995-12-08
DE4430204A1 (en) 1996-02-29
KR960006920A (en) 1996-03-22
EP0700682A3 (en) 1996-05-29
JP3838680B2 (en) 2006-10-25
JPH0859505A (en) 1996-03-05
CA2156990A1 (en) 1996-02-27

Similar Documents

Publication Publication Date Title
AU6889896A (en) Syringe serving also as an ampule and syringe for collecting blood
EP0755690A3 (en) Hypodermic cannula
AU688399B2 (en) Disposable diaper
AU4000293A (en) Ophthalmologic cannula
AU5509098A (en) Improved hypodermic syringe
AU6048994A (en) Blood lancing device
AU6643994A (en) Device for the preparation of a solution, a suspension or an emulsion of a medicinal substance
AU2844299A (en) Safety syringe for medical use
AU4267396A (en) Modified cannula
AU3025795A (en) Compositions which are suitable for employment as antidotes to blood anticoagulants, and their use
AU4069395A (en) Optically active benzothiepin derivative, its preparation and use
AU4959690A (en) Single use hypodermic syringe
AU2066492A (en) Hemostasis cannula
AU3025695A (en) Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants, and its use
AU7672094A (en) Single-use syringe
AU4703589A (en) Blood separating agent
AU3289895A (en) Blood compatible, shear sensitive formulations
AU4967290A (en) Single-use syringe
AU2899597A (en) Disposable syringe
AU2752888A (en) Use of known compounds, novel compounds and the use and processes for preparation thereof
GR3035710T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds as well as medicaments containing them
AU6944696A (en) Novel phenylacetic acid derivatives and medicinal composition containing the same
AU2371397A (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
AU4362097A (en) Syringe for medicinal purposes
AU4821190A (en) Disposable hypodermic syringe

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired